Jelinek T, Kilian A H, Westermeier A, Pröll S, Kabagambe G, Nothdurft H D, von Sonnenburg F, Löscher T
Department of Infectious Diseases and Tropical Medicine, University of Munich, Germany.
Trop Med Int Health. 1999 Jul;4(7):476-80. doi: 10.1046/j.1365-3156.1999.00428.x.
It has been proposed that polymorphisms of the Merozoite Surface Protein 1 and 2 (MSP1 and MSP2) and the Glutamate Rich Protein (GLURP) genes can be considered as genetic markers for the genotyping of field populations of Plasmodium falciparum. During a field study on in vivo drug resistance against chloroquine, sulphadoxine/pyrimethamine (S/P) and cotrimoxazole in West Uganda, sensitive and resistant isolates were collected from patients by fingerprick for genotyping. 59 (72.8%) of the 81 P. falciparum samples isolated at day 0 showed multiclonal infection with 2-7 clones. Among the isolates we investigated, presence of the allelic family MAD20 of MSP1 at day 0 was significantly (P = 0.0041) associated with decreased resistance to antimalarials. Use of this method in a field study on in vivo drug resistance demonstrates another potential application of genotyping as a tool for epidemiological investigations.
有人提出,裂殖子表面蛋白1和2(MSP1和MSP2)以及富含谷氨酸蛋白(GLURP)基因的多态性可被视为恶性疟原虫野外种群基因分型的遗传标记。在乌干达西部进行的一项关于体内对氯喹、磺胺多辛/乙胺嘧啶(S/P)和复方新诺明耐药性的实地研究中,通过手指采血从患者身上收集敏感和耐药分离株进行基因分型。在第0天分离的81株恶性疟原虫样本中,59株(72.8%)显示为2 - 7个克隆的多克隆感染。在我们研究的分离株中,第0天MSP1等位基因家族MAD20的存在与对抗疟药耐药性降低显著相关(P = 0.0041)。在一项关于体内耐药性的实地研究中使用这种方法,证明了基因分型作为流行病学调查工具的另一种潜在应用。